Mirum Pharmaceuticals Inc Investor Relations Material
Latest events
Q4 2023
Mirum Pharmaceuticals Inc
Access the full event backlog
Slides, Transcripts, and Reports from 9,000+ public companies
Latest reports from Mirum Pharmaceuticals Inc
Access all reports
Mirum Pharmaceuticals, Inc. is a biopharmaceutical company focused on the development and commercialization of novel therapies for debilitating rare and orphan diseases.
The company was founded with the goal of developing drugs that can address unmet medical needs. It has developed two lead candidates. These two therapies are designed to treat patients suffering from rare genetic disorders that affect their metabolism, such as phenylketonuria (PKU).
Key slides for Mirum Pharmaceuticals Inc
Q4 2023
Mirum Pharmaceuticals Inc
Q3 2023
Mirum Pharmaceuticals Inc
Latest articles
Remembering Daniel Kahneman: Transforming Psychology and Economics
Explore Daniel Kahneman's legacy in psychology and economics, highlighting his impact on decision-making and behavioral economics.
28 Mar 2024
Deere & Company: Shaping Agriculture & Construction Since 1837
Exploring Deere & Company: A global leader in agriculture & construction equipment since 1837.
28 Mar 2024
Jane Fraser: First Female Leader of a Major Wall Street Bank
Discover the journey of Jane Fraser, CEO of Citigroup and the first female leader of a major Wall Street bank.
28 Mar 2024
Ticker symbol
Country
🇺🇸 United States